Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco
About this trial
This clinical trial explores and implements methods to improve informed decision making (IDM) regarding precision oncology tests amongst veterans with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Precision oncology, the use of germline genetic testing and tumor-based molecular assays to inform cancer care, has become an important aspect of evidence-based care for men with advanced prostate cancer. Veterans with metastatic castrate-resistant prostate cancer may not be carrying out IDM due to unmet decisional needs. An informed decision is a choice based on complete and accurate information. The information gained from this study will help researchers develop a decision support intervention (DSI) and implement the intervention. A DSI may serve as a valuable tool to reduce ongoing racial disparities in genetic testing and encourage enrollment to precision oncology trials.
Eligibility criteria
Qualifiers
Age 18 years or older.
Able to understand study procedures and to comply with them for the entire length of the study.
Able to understand a written informed consent document and willing to sign it.
Able to speak, read, and understand English.
Disqualifiers
For patient-participants undergoing genetic testing, if results of the genetic tests have already been disclosed to the participant, they are not eligible.
If they do not meet any of the inclusion criteria above.
Prior receipt of germline testing.
Prior participation in Stage 1 for germline testing.
Trial design
Treatments tested in this trial
- Participant Surveys
- Mobile app
Treatment groups
250 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of California, San Francisco
Lead sponsor
United States Department of Defense
Collaborator
Source ClinicalTrials.gov